SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe

Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment ...
JD Supra

The Fourth Pillar Of An AML Program: Establishing An Independent Audit That Stands Up To Scrutiny

An AML program is only as strong as its weakest pillar. Internal controls can look airtight. Compliance officers can be seasoned. Training can be thorough. But if the independent audit is weak, ...
Morningstar

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program

Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia ...